CompoAtlas

GLANDLINE THYROLUX

Food supplement declared in France, declaration No 2022-6-1701

GLANDLINE THYROLUX is a food supplement declared in France. Status: retiré du marché le 19 July 2024. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
SENSILAB Ltd.
Status
Retiré du marché le 19 July 2024
Form
Capsule
Daily dose
2 CAPSULES

Declaration 234529, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Ocimum tenuiflorum L.FeuilleExtrait sec aqueux150 mg
Commiphora mukul Engl.Gomme résineExtrait sec aqueux100 mg
Schisandra chinensis (Turcz.) Baill.FruitExtrait sec aqueux100 mg
Fucus vesiculosus L.ThalleExtrait sec aqueux75 mg

Other active ingredients

NamePer day
Tyrosinenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Oxyde de magnésiumMagnésium250 mg300 mg
Bisglycinate de manganèseManganèse8 mg (niveau de sécurité)3.5 mg
Levure enrichie en séléniumSélénium255 µg50 µg
Gluconate de zincZinc25 mg15 mg

Additives

E464, E470b

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Si vous êtes hypersensibleou allergique à l‘un des ingrédients de ce produit ou utilisez des médicaments, consultezvotre médecin avant utilisation. Une utilisation prolongée n‘est pas recommandée. Ceproduit est déconseillé aux enfants de moins de 10 ans, adolescents, aux femmes enceinteset allaitantes, aux personnes souffrant de troubles thyroïdiens ou suivant un traitementanticoagulant.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Enter to analyse, Shift+Enter for a new line